Analyze Diet
Journal of clinical microbiology1999; 37(12); 4042-4044; doi: 10.1128/JCM.37.12.4042-4044.1999

Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks.

Abstract: This paper describes the kinetics of the human granulocytic ehrlichiosis agent in the blood of horses experimentally infected by intravenous inoculation with infected leukocytes and by infected ticks as evaluated by using a real-time quantitative PCR assay. The data obtained indicated differences in the period of incubation, duration of rickettsemia, and initial and maximal ehrlichial loads between the two routes of infection.
Publication Date: 1999-11-24 PubMed ID: 10565928PubMed Central: PMC85876DOI: 10.1128/JCM.37.12.4042-4044.1999Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study examines the behavior of the bacteria causing human granulocytic ehrlichiosis in horses. It does this by testing two methods of infection: through infected white blood cells and through tick bites, then comparing the differences in infection progression.

Understanding Human Granulocytic Ehrlichiosis

  • Ehrlichiosis, in this case human granulocytic ehrlichiosis, is an infectious disease caused by bacteria of the Ehrlichia genus.
  • These bacteria are typically transmitted via tick bites and are pathogenic to both humans and animals, including horses.
  • In terms of symptoms and impact on host health, it can range from mild to potentially life-threatening.

Experimental Transmission of Ehrlichiosis

  • The researchers in this study experimented with two methods of transmitting the ehrlichiosis-causing agent.
  • One was direct injection of infected leukocytes (white blood cells) via the intravenous route, effectively bypassing the typical route of transmission (tick bites).
  • The other method was via the ‘natural’ route, that is, through tick bites.

Monitoring the Infection & Results

  • Following the initiation of infection, the researchers closely monitored various parameters to understand the progression of the disease.
  • This included the period of incubation (how long from infection to first symptoms), the length of rickettsemia (presence of bacteria in the blood), and the initial and peak loads of the ehrlichial bacteria in the blood.
  • The whole process was assessed with the help of real-time quantitative PCR, a tool that allows the quantification of specific DNA or RNA molecules, including those of the bacteria responsible for ehrlichiosis.
  • The results showed differences in all monitored parameters between the two modes of infection, indicating that the route of transmission could have effects on the progression of the disease.

Cite This Article

APA
Pusterla N, Leutenegger CM, Chae JS, Lutz H, Kimsey RB, Dumler JS, Madigan JE. (1999). Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks. J Clin Microbiol, 37(12), 4042-4044. https://doi.org/10.1128/JCM.37.12.4042-4044.1999

Publication

ISSN: 0095-1137
NlmUniqueID: 7505564
Country: United States
Language: English
Volume: 37
Issue: 12
Pages: 4042-4044

Researcher Affiliations

Pusterla, N
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California 95616, USA. npusterla@ucdavis.edu
Leutenegger, C M
    Chae, J S
      Lutz, H
        Kimsey, R B
          Dumler, J S
            Madigan, J E

              MeSH Terms

              • Animals
              • Colony Count, Microbial
              • DNA, Bacterial / blood
              • Ehrlichia / genetics
              • Ehrlichia / isolation & purification
              • Ehrlichia / physiology
              • Ehrlichiosis / microbiology
              • Ehrlichiosis / transmission
              • Ehrlichiosis / veterinary
              • Horse Diseases / microbiology
              • Horse Diseases / pathology
              • Horse Diseases / transmission
              • Horses
              • Humans
              • Ixodes / microbiology
              • Leukocytes / microbiology
              • Polymerase Chain Reaction / methods

              Grant Funding

              • A14213 / PHS HHS

              References

              This article includes 19 references
              1. Bakken JS, Dumler JS, Chen S-M, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper midwest United States. A new species emerging?. JAMA 1994;272:212–218.
                pubmed: 8022040
              2. Barlough JE, Madigan JE, DeRock E, Dumler JS, Bakken JS. Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic ehrlichia (HGE agent). J Clin Microbiol 1995;33:3333–3334.
                pmc: PMC228702pubmed: 8586731
              3. Barthold SW. Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J Infect Dis 1991;163:419–420.
                pubmed: 1988530
              4. Chae J-S, Pusterla N, Kimsey RB, DeRock E, Blanchard MT, Dumler JS, Madigan JE. Experimental transmission of human granulocytic ehrlichia agent in horses by experimentally infected ticks (Ixodes scapularis). Submitted for publication.
                pubmed: 12485358
              5. Chen S-M, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994;32:589–595.
                pmc: PMC263091pubmed: 8195363
              6. De Souza MS, Smith AL, Beck DS, Kim LJ, Hansen GM Jr, Barthold SW. Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation. Infect Immun 1993;61:4493–4497.
                pmc: PMC281186pubmed: 8406842
              7. Fritz CL, Glaser CA. Ehrlichiosis. Infect Dis Clin N Am 1998;12:123–136.
                pubmed: 9494834
              8. Gaunt SD, Corstvet RE, Berry CM, Brennan B. Isolation of Ehrlichia canis from dogs following subcutaneous inoculation. J Clin Microbiol 1996;34:1429–1432.
                pmc: PMC229037pubmed: 8735093
              9. Gern L, Schaible UE, Simon M. Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect Dis 1993;167:971–975.
                pubmed: 8450262
              10. Hodzic E, Fish D, Maretzki CM, De Silva AM, Feng S, Barthold SW. Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol 1998;36:3574–3578.
                pmc: PMC105242pubmed: 9817875
              11. Katavolos P, Armstrong PM, Dawson JE, Telford SR. Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J Infect Dis 1998;177:1422–1425.
                pubmed: 9593039
              12. Madigan JE, Hietala S, Chalmers S, DeRock E. Seroepidemiologic survey of antibodies to Ehrlichia equi in horses of northern California. J Am Vet Med Assoc 1990;196:1962–1964.
                pubmed: 2195000
              13. Madigan JE, Richter PJ, Kimsey RB, Barlough JE, Bakken JS, Dumler JS. Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis 1995;172:1141–1144.
                pubmed: 7561199
              14. Madigan JE, Barlough JE, Dumler JS, Schankman NS, DeRock E. Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia. J Clin Microbiol 1996;34:434–435.
                pmc: PMC228814pubmed: 8789032
              15. Petrovec M, Furlan SL, Zupanc TA, Strle F, Brouqui P, Roux V, Dumler JS. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997;35:1556–1559.
                pmc: PMC229786pubmed: 9163481
              16. Pusterla N, Huder JB, Leutenegger CM, Braun U, Madigan JE, Lutz H. Quantitative real-time PCR for detection of members of the Ehrlichia phagocytophila genogroup in host animals and Ixodes ricinus ticks. J Clin Microbiol 1999;37:1329–1331.
                pmc: PMC84766pubmed: 10203480
              17. Reubel GH, Kimsey RB, Barlough JE, Madigan JE. Experimental transmission of Ehrlichia equi to horses through naturally infected ticks (Ixodes pacificus) from Northern California. J Clin Microbiol 1998;36:2131–2134.
                pmc: PMC105004pubmed: 9650983
              18. Rikihisa Y. The tribe Ehrlichieae and ehrlichial diseases. Clin Microbiol Rev 1991;4:286–308.
                pmc: PMC358200pubmed: 1889044
              19. Schaible UE, Gern L, Wallich R, Kramer MD, Prester M, Simon MM. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen. Immunol Lett 1993;36:219–226.
                pubmed: 8349316